Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 24:210436. doi: 10.1148/radiol.2021210436

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2021 by the Radiological Society of North America, Inc.

This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

PMC Copyright notice

Example of a 60-year-old male patient on surveillance for smoldering myeloma with typical vaccination-associated findings. (a) Coronal maximum intensity projection (MIP) of 18F-FDG-PET and (b) fused axial 18F-FDG-PET/CT showing FDG avidity in the left deltoid muscle (SUVmax 5.9 g/ml) from the injection site (arrowhead) and ipsilateral reactive FDG-avid draining axillary lymph nodes (SUVmax 9.6 g/ml) (arrow), which are normal-sized on CT. — Example of a 60-year-old male patient on surveillance for smoldering myeloma with typical vaccination-associated findings. (a) Coronal maximum intensity projection (MIP) of ¹⁸F-FDG-PET and (b) fused axial ¹⁸F-FDG-PET/CT showing FDG avidity in the left deltoid muscle (SUV_max 5.9 g/ml) from the injection site (arrowhead) and ipsilateral reactive FDG-avid draining axillary lymph nodes (SUV_max 9.6 g/ml) (arrow), which are normal-sized on CT.